Chengzhi Shareholding Co Ltd

SHE:000990 China Biotechnology
Market Cap
$1.79 Billion
CN¥13.11 Billion CNY
Market Cap Rank
#7607 Global
#1323 in China
Share Price
CN¥10.79
Change (1 day)
+9.99%
52-Week Range
CN¥6.83 - CN¥10.79
All Time High
CN¥30.90
Categories
Companies in China Biotechnology Cannabis & CBD
About

Chengzhi Co., Ltd. engages in the clean energy, semiconductor display material, medical healthcare, and life science businesses in China. The company produces and sells gas products, including carbon monoxide, syngas, butane, isobutanal, ethane, propane, crude benzene, ethylene, hydrogen, propylene, methanol, butylene glycol, Butanoctyl, diolefin, and other chemicals. It also produces and sells l… Read more

Chengzhi Shareholding Co Ltd (000990) - Net Assets

Latest net assets as of September 2025: CN¥18.81 Billion CNY

Based on the latest financial reports, Chengzhi Shareholding Co Ltd (000990) has net assets worth CN¥18.81 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥27.52 Billion) and total liabilities (CN¥8.72 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥18.81 Billion
% of Total Assets 68.33%
Annual Growth Rate 21.95%
5-Year Change 12.19%
10-Year Change 614.16%
Growth Volatility 106.4

Chengzhi Shareholding Co Ltd - Net Assets Trend (1997–2024)

This chart illustrates how Chengzhi Shareholding Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Chengzhi Shareholding Co Ltd (1997–2024)

The table below shows the annual net assets of Chengzhi Shareholding Co Ltd from 1997 to 2024.

Year Net Assets Change
2024-12-31 CN¥18.73 Billion +1.46%
2023-12-31 CN¥18.46 Billion -0.27%
2022-12-31 CN¥18.51 Billion +0.27%
2021-12-31 CN¥18.46 Billion +10.57%
2020-12-31 CN¥16.70 Billion +2.16%
2019-12-31 CN¥16.34 Billion +0.13%
2018-12-31 CN¥16.32 Billion +1.60%
2017-12-31 CN¥16.07 Billion +3.53%
2016-12-31 CN¥15.52 Billion +491.62%
2015-12-31 CN¥2.62 Billion +11.99%
2014-12-31 CN¥2.34 Billion +38.31%
2013-12-31 CN¥1.69 Billion +2.61%
2012-12-31 CN¥1.65 Billion -0.35%
2011-12-31 CN¥1.66 Billion +1.54%
2010-12-31 CN¥1.63 Billion -2.49%
2009-12-31 CN¥1.67 Billion +24.35%
2008-12-31 CN¥1.35 Billion +31.41%
2007-12-31 CN¥1.02 Billion +2.60%
2006-12-31 CN¥997.75 Million +2.26%
2005-12-31 CN¥975.70 Million +4.90%
2004-12-31 CN¥930.16 Million +10.79%
2003-12-31 CN¥839.58 Million +7.10%
2002-12-31 CN¥783.92 Million +8.94%
2001-12-31 CN¥719.56 Million +8.44%
2000-12-31 CN¥663.54 Million +313.36%
1999-12-31 CN¥160.52 Million +24.37%
1998-12-31 CN¥129.07 Million +46.42%
1997-12-31 CN¥88.15 Million --

Equity Component Analysis

This analysis shows how different components contribute to Chengzhi Shareholding Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 362405737300.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥3.62 Billion 20.32%
Common Stock CN¥1.22 Billion 6.81%
Other Comprehensive Income CN¥588.10 Million 3.30%
Other Components CN¥12.41 Billion 69.56%
Total Equity CN¥17.83 Billion 100.00%

Chengzhi Shareholding Co Ltd Competitors by Market Cap

The table below lists competitors of Chengzhi Shareholding Co Ltd ranked by their market capitalization.

Company Market Cap
Vobile Group Limited
OTCQX:VOBIF
 		$935.46 Million
Tian Jin Motor Dies Co Ltd
SHE:002510
 		$935.99 Million
BK TIROL VORARLBG
F:ZTY
 		$936.01 Million
Braskem SA Class A
NYSE:BAK
 		$936.09 Million
New World Development Company Limited
PINK:NWWDF
 		$934.90 Million
Vipshop Holdings Limited
NYSE:VIPS
 		$934.86 Million
Beijing SuperMap Software Co Ltd
SHE:300036
 		$934.64 Million
CareCloud Inc.
NASDAQ:CCLDO
 		$934.50 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Chengzhi Shareholding Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 17,650,708,059 to 17,832,498,223, a change of 181,790,164 (1.0%).
  • Net income of 230,588,927 contributed positively to equity growth.
  • Dividend payments of 226,550,594 reduced retained earnings.
  • Other comprehensive income increased equity by 599,612,060.
  • Other factors decreased equity by 421,860,229.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥230.59 Million +1.29%
Dividends Paid CN¥226.55 Million -1.27%
Other Comprehensive Income CN¥599.61 Million +3.36%
Other Changes CN¥-421.86 Million -2.37%
Total Change CN¥- 1.03%

Book Value vs Market Value Analysis

This analysis compares Chengzhi Shareholding Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.74x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 20.21x to 0.74x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1997-12-31 CN¥0.53 CN¥10.79 x
1998-12-31 CN¥0.76 CN¥10.79 x
1999-12-31 CN¥0.95 CN¥10.79 x
2000-12-31 CN¥4.24 CN¥10.79 x
2001-12-31 CN¥4.45 CN¥10.79 x
2002-12-31 CN¥4.74 CN¥10.79 x
2003-12-31 CN¥5.12 CN¥10.79 x
2004-12-31 CN¥5.38 CN¥10.79 x
2005-12-31 CN¥5.63 CN¥10.79 x
2006-12-31 CN¥3.59 CN¥10.79 x
2007-12-31 CN¥3.75 CN¥10.79 x
2008-12-31 CN¥4.75 CN¥10.79 x
2009-12-31 CN¥5.51 CN¥10.79 x
2010-12-31 CN¥5.31 CN¥10.79 x
2011-12-31 CN¥5.39 CN¥10.79 x
2012-12-31 CN¥5.43 CN¥10.79 x
2013-12-31 CN¥5.57 CN¥10.79 x
2014-12-31 CN¥7.25 CN¥10.79 x
2015-12-31 CN¥6.35 CN¥10.79 x
2016-12-31 CN¥39.45 CN¥10.79 x
2017-12-31 CN¥12.69 CN¥10.79 x
2018-12-31 CN¥12.91 CN¥10.79 x
2019-12-31 CN¥13.28 CN¥10.79 x
2020-12-31 CN¥13.57 CN¥10.79 x
2021-12-31 CN¥14.53 CN¥10.79 x
2022-12-31 CN¥14.54 CN¥10.79 x
2023-12-31 CN¥14.53 CN¥10.79 x
2024-12-31 CN¥14.67 CN¥10.79 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Chengzhi Shareholding Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 1.29%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 2.08%
  • • Asset Turnover: 0.41x
  • • Equity Multiplier: 1.52x
  • Recent ROE (1.29%) is below the historical average (5.84%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1997 25.29% 8.93% 1.52x 1.86x CN¥12.22 Million
1998 20.51% 10.00% 1.09x 1.89x CN¥11.92 Million
1999 19.90% 14.07% 0.75x 1.90x CN¥14.01 Million
2000 6.37% 14.73% 0.35x 1.24x CN¥-23.02 Million
2001 6.77% 10.27% 0.48x 1.39x CN¥-21.48 Million
2002 7.79% 6.82% 0.58x 1.99x CN¥-15.68 Million
2003 7.31% 3.85% 0.91x 2.08x CN¥-20.58 Million
2004 5.96% 4.30% 0.67x 2.08x CN¥-32.50 Million
2005 5.91% 3.55% 0.73x 2.27x CN¥-34.50 Million
2006 5.87% 3.61% 0.63x 2.57x CN¥-35.77 Million
2007 5.62% 2.58% 0.87x 2.49x CN¥-39.71 Million
2008 2.23% 1.09% 0.88x 2.31x CN¥-95.81 Million
2009 2.58% 1.43% 0.77x 2.35x CN¥-116.88 Million
2010 1.37% 0.69% 0.89x 2.26x CN¥-135.21 Million
2011 1.98% 1.06% 0.89x 2.10x CN¥-127.93 Million
2012 1.69% 0.81% 1.12x 1.89x CN¥-133.58 Million
2013 3.14% 1.30% 1.20x 2.02x CN¥-113.17 Million
2014 3.16% 1.83% 1.02x 1.69x CN¥-158.62 Million
2015 5.67% 3.41% 0.82x 2.03x CN¥-105.42 Million
2016 0.72% 4.30% 0.13x 1.32x CN¥-1.42 Billion
2017 5.08% 14.20% 0.27x 1.32x CN¥-781.83 Million
2018 5.25% 14.47% 0.25x 1.45x CN¥-768.65 Million
2019 2.74% 6.40% 0.29x 1.49x CN¥-1.17 Billion
2020 2.15% 3.65% 0.40x 1.48x CN¥-1.29 Billion
2021 5.71% 8.28% 0.50x 1.38x CN¥-756.73 Million
2022 0.29% 0.43% 0.48x 1.39x CN¥-1.72 Billion
2023 1.01% 1.43% 0.48x 1.46x CN¥-1.59 Billion
2024 1.29% 2.08% 0.41x 1.52x CN¥-1.55 Billion

Industry Comparison

This section compares Chengzhi Shareholding Co Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $5,721,575,041
  • Average return on equity (ROE) among peers: 11.21%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Chengzhi Shareholding Co Ltd (000990) CN¥18.81 Billion 25.29% 0.46x $934.96 Million
Shenzhen CAU Technology Co Ltd (000004) $85.28 Million -13.04% 0.97x $80.66 Million
Pacific Shuanglin Bio pharmacy Co Ltd (000403) $687.82 Million 11.47% 1.00x $1.02 Billion
Nanhua Bio Medicine Co Ltd (000504) $134.48 Million 10.88% 3.14x $288.51 Million
Jiangsu Sihuan Bioengineering Co Ltd (000518) $915.76 Million -0.65% 0.06x $253.71 Million
Hualan Biological EngineeringInc (002007) $6.88 Billion 18.64% 0.10x $1.99 Billion
Da An Gene Co Ltd of Sun Yat-Sen University (002030) $7.66 Billion 47.23% 0.35x $793.09 Million
Shanghai RAAS Blood Products Co Ltd Class A (002252) $31.94 Billion 6.87% 0.05x $3.75 Billion
Baolingbao Biology Co Ltd (002286) $2.04 Billion 5.44% 0.31x $403.60 Million
Tibet Cheezheng Tibetan Medicine Co Ltd (002287) $1.14 Billion 14.05% 0.13x $344.80 Million